Medicare Enrolled

Dr. David Chin Yee, MD

Retina Specialist (Ophthalmology) Physician · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1100 JOHNSON FERRY RD, Atlanta, GA 30342
4042559096
In practice since 2009 (17 years)
NPI: 1740424563 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chin Yee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chin Yee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chin Yee

Dr. David Chin Yee is a retina specialist physician in Atlanta, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Chin Yee performed 48,460 Medicare services across 3,092 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chin Yee received a total of $606,060 from 33 pharmaceutical and/or device companies across 866 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chin Yee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 12% volume in GA $606,060 industry payments

Medicare Practice Summary

Medicare Utilization ↗
48,460
Medicare services
Top 12% in GA for retina specialist (ophthalmology) physician
3,092
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,851 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
38,160 $29 $107
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,315 $31 $129
Injection, ranibizumab, 0.1 mg 2,308 $181 $1,082
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,680 $96 $1,473
Aflibercept eye injection (Eylea) 1,224 $688 $2,100
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
969 $86 $255
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
483 $155 $372
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
370 $27 $200
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
341 $67 $175
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
255 $120 $292
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
175 $109 $400
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
70 $48 $300
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
45 $1,752 $3,750
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
38 $102 $285
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
14 $35 $361
Retinal detachment repair with fluid drainage
A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina.
13 $926 $6,890
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$606,060
Total received (2018-2024)
Avg $86,580/year across 7 years
Top 6% in GA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
866
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$551,155 (90.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,314 (7.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,591 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$266,245
2023
$163,642
2022
$73,413
2021
$35,553
2020
$17,690
2019
$42,611
2018
$6,907

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$95,396
Astellas Pharma US Inc
$61,803
Apellis Pharmaceuticals, Inc.
$51,779
Genentech USA, Inc.
$29,154
Regeneron Pharmaceuticals, Inc.
$12,228
Alimera Sciences, Inc.
$7,096
F. Hoffmann-La Roche AG
$4,572
EyePoint Pharmaceuticals US, Inc.
$3,520
Bausch & Lomb Americas Inc.
$398
Biogen, Inc.
$161
ABBVIE INC.
$59
Sandoz Inc.
$37
ANI Pharmaceuticals, Inc.
$25
Astellas Pharma Global Development
$16
Top 3 companies account for 78.5% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$198,025
Apellis Pharmaceuticals, Inc.
$116,738
Genentech USA, Inc.
$92,140
Astellas Pharma US Inc
$85,711
Alimera Sciences, Inc.
$42,380
Novartis Pharmaceuticals Corporation
$36,057
Regeneron Pharmaceuticals, Inc.
$12,529
EyePoint Pharmaceuticals US, Inc.
$5,503
Allergan Inc.
$5,150
F. Hoffmann-La Roche AG
$4,572
Alcon Vision LLC
$3,070
Notal Vision, Inc.
$805
ABBVIE INC.
$610
Bausch & Lomb Americas Inc.
$432
NotalVision
$400
Biogen, Inc.
$270
Carl Zeiss Meditec USA, Inc.
$253
Allergan, Inc.
$191
AbbVie Inc.
$184
Bausch & Lomb, a division of Bausch Health US, LLC
$157
Sight Sciences, Inc.
$147
Dompe US, Inc.
$137
RxSight Inc
$125
Kala Pharmaceuticals, Inc.
$120
Coherus Biosciences Inc.
$90
Mallinckrodt LLC
$58
NEW WORLD MEDICAL,INC.
$48
Carl Zeiss Meditec AG
$39
Sandoz Inc.
$37
ANI Pharmaceuticals, Inc.
$25
Sun Pharmaceutical Industries Inc.
$23
LKC Technologies, Inc.
$19
Astellas Pharma Global Development
$16
Top 3 companies account for 67.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Ahmed Glaucoma Valve · BEOVU · BYOOVIZ · CIRRUS HD-OCT · CLARUS 700 · Cequa · Cimerli · Constellation · DEXYCU · DUREZOL · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · ForeseeHome · ILUVIEN · INVELTYS · Iluvien · Izervay · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · Lucentis · MIEBO · NGENUITY · None Specified · OMNI SURGICAL SYSTEM · OXERVATE · OZURDEX · PROLENSA · PURIFIED CORTROPHIN GEL · SUSVIMO · Susvimo · Syfovre · VABYSMO · Vabysmo · XIPERE · YUTIQ · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for retina specialist (ophthalmology) physician in GA.

Looking for a retina specialist physician in Atlanta?
Compare retina specialist physicians in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
7
Per 100K population
0.7
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chin Yee is a mixed practice specialist, with above-average Medicare volume (top 12% in GA), with speaking/promotional industry engagement in the top 6% of GA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chin Yee experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Chin Yee performed 38,160 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chin Yee receive payments from pharmaceutical companies?
Yes. Dr. Chin Yee received a total of $606,060 from 33 companies across 866 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chin Yee's costs compare to other retina specialist physicians in Atlanta?
Dr. Chin Yee's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chin Yee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →